GENMARK DIAGNOSTICS INC's ticker is GNMK and the CUSIP is 372309104. A total of 151 filers reported holding GENMARK DIAGNOSTICS INC in Q2 2020. The put-call ratio across all filers is 0.35 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $393,000 | -57.7% | 27,701 | -56.2% | 0.00% | -60.0% |
| Q2 2020 | $930,000 | -29.7% | 63,229 | -80.3% | 0.01% | -41.2% |
| Q1 2020 | $1,322,000 | +12.1% | 320,912 | +30.9% | 0.02% | +41.7% |
| Q4 2019 | $1,179,000 | +141.1% | 245,118 | +204.0% | 0.01% | +100.0% |
| Q3 2019 | $489,000 | -52.2% | 80,627 | -61.7% | 0.01% | -66.7% |
| Q4 2018 | $1,022,000 | -26.9% | 210,270 | +10.5% | 0.02% | -10.0% |
| Q3 2018 | $1,398,000 | +26.5% | 190,270 | +9.8% | 0.02% | +17.6% |
| Q2 2018 | $1,105,000 | -4.0% | 173,247 | -18.1% | 0.02% | -10.5% |
| Q1 2018 | $1,151,000 | +8.8% | 211,664 | -16.6% | 0.02% | 0.0% |
| Q4 2017 | $1,058,000 | – | 253,700 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 2,730,000 | $11,384,000 | 2.77% |
| CADIAN CAPITAL MANAGEMENT, LP | 5,017,483 | $20,923,000 | 1.28% |
| Ghost Tree Capital, LLC | 500,000 | $2,085,000 | 0.49% |
| Bellevue Group AG | 773,677 | $3,226,000 | 0.34% |
| NEEDHAM INVESTMENT MANAGEMENT LLC | 180,000 | $750,000 | 0.20% |
| Penn Capital Management Company, LLC | 543,715 | $2,267,000 | 0.16% |
| HighTower Advisors, LLC | 2,355,942 | $9,826,000 | 0.08% |
| Granite Investment Partners, LLC | 215,760 | $900,000 | 0.06% |
| WRAPMANAGER INC | 39,547 | $165,000 | 0.05% |
| Alyeska Investment Group, L.P. | 1,563,881 | $6,521,000 | 0.05% |